PNPO, pyridoxamine 5'-phosphate oxidase, 55163

N. diseases: 60; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 GeneticVariation disease BEFREE More than 25 different mutations in hPNPO, which result in reduced catalytic activity, have been described for PNPO-deficiency NEE. 31616300 2019
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 GeneticVariation disease UNIPROT Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes. 27864847 2017
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Systemic Manifestations in Pyridox(am)ine 5'-Phosphate Oxidase Deficiency. 28985901 2017
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies. 27781031 2016
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Cirrhosis associated with pyridoxal 5'-phosphate treatment of pyridoxamine 5'-phosphate oxidase deficiency. 25256445 2014
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Pyridoxine responsiveness in novel mutations of the PNPO gene. 24658933 2014
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. 24645144 2014
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 Biomarker disease GENOMICS_ENGLAND Typical and atypical phenotypes of PNPO deficiency with elevated CSF and plasma pyridoxamine on treatment. 24266778 2014
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 GeneticVariation disease UNIPROT Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. 23708187 2013
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Seizures with decreased levels of pyridoxal phosphate in cerebrospinal fluid. 23419474 2013
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy. 21292558 2011
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 CausalMutation disease CLINVAR Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency. 20370816 2010
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 GeneticVariation disease UNIPROT Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. 15772097 2005
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 Biomarker disease GENOMICS_ENGLAND Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. 15772097 2005
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 GermlineCausalMutation disease ORPHANET Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. 15772097 2005
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 Biomarker disease CTD_human
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency
0.710 GeneticVariation disease CLINVAR
CUI: C0038220
Disease: Status Epilepticus
Status Epilepticus
0.400 Biomarker disease CTD_human Linear regression analysis identified a direct proportional relationship between PLK/PNPO immunoreactivity and normalized population spike amplitude ratio in the dentate gyrus and the CA1 region as excluded the data obtained from 4 weeks after SE. 19356691 2009
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.400 Biomarker disease GENOMICS_ENGLAND Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. 15772097 2005
CUI: C0038220
Disease: Status Epilepticus
Status Epilepticus
0.400 Biomarker disease HPO
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.400 Biomarker disease HPO
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.310 Biomarker disease BEFREE We hypothesized that the gene PNPO (pyridoxine 5'-phosphatase oxidase gene) might be a candidate for susceptibility to schizophrenia because PNPO encodes pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5), a rate-limiting enzyme in pyridoxal 5'-phosphate (PLP, vitamin B(6)) synthesis. 17851041 2007
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.310 GeneticVariation disease LHGDN We hypothesized that the gene PNPO (pyridoxine 5'-phosphatase oxidase gene) might be a candidate for susceptibility to schizophrenia because PNPO encodes pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5), a rate-limiting enzyme in pyridoxal 5'-phosphate (PLP, vitamin B(6)) synthesis. 17851041 2007
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.310 Biomarker disease PSYGENET We hypothesized that the gene PNPO (pyridoxine 5'-phosphatase oxidase gene) might be a candidate for susceptibility to schizophrenia because PNPO encodes pyridoxamine 5'-phosphate oxidase (EC 1.4.3.5), a rate-limiting enzyme in pyridoxal 5'-phosphate (PLP, vitamin B(6)) synthesis. 17851041 2007
CUI: C0270823
Disease: Petit mal status
Petit mal status
0.300 Biomarker disease CTD_human Enhanced pyridoxal 5'-phosphate synthetic enzyme immunoreactivities do not contribute to GABAergic inhibition in the rat hippocampus following pilocarpine-induced status epilepticus. 19356691 2009